col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


54 Results       Page 1

 [1] 
Bentham Science: Current Topics in Medicinal Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2023―Apr―14 SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research Edeildo Ferreira da Silva-Júnior, Weslany Souza Rocha, Peng Zhan
2 [GO] 2023―Mar―28 Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective Praveen Kumar Verma, Varun Aggarwal, Ekta Bala, Pawan Kumar, Pankaj Raizada, Pardeep Singh
3 [GO] 2023―Feb―23 Investigating Biomarkers for COVID-19 Morbidity and Mortality Marco Fiore, Flavio Maria Ceci, Giampiero Ferraguti, Marco Lucarelli, Antonio Angeloni, Enea Bonci, et al. (+12)
4 [GO] 2023―Jan―31 Contributions of Medicinal Chemistry During the Pandemic of Covid-19 Shampa Ghosh, Jitendra Kumar Sinha
5 [GO] 2023―Jan―27 SAR Based Review on Diverse Heterocyclic Compounds with Various Potential Molecular Targets in the Fight against Covid-19: A Medicinal Chemist Perspective Mohammad Mumtaz Alam, Anish Madan, Mansi Garg, Garvit Satija, Barkha Sharma, M Shaquiquzzaman, et al. (+6)
6 [GO] 2022―Dec―27 Piezoelectric biosensors and nanomaterials-based therapeutics for coronavirus and other viruses: A Mini-review Rakesh Bhaskar, Madeshwaran Sekkarapatti Ramasamy, Sung Soon Han
7 [GO] 2022―Dec―26 Probing the neuro-psychological changes observed with the administration of COVID-19 Drugs Indranath Chatterjee, Videsha Bansal
8 [GO] 2022―Dec―06 The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area Zhongji Meng
9 [GO] 2022―Dec―06 An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors Dima A. Sabbah
10 [GO] 2022―Dec―02 Repurposing of chemotherapeutics to combat COVID-19 Anil Kumar Saxena, Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede
11 [GO] 2022―Nov―04 Structure Based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design. Anusuya Shanmugam, Anbazhagan Venkattappan, M. Michael Gromiha
12 [GO] 2022―Oct―24 Exploring the targets of novel corona virus and docking-based screening of potential natural inhibitors to combat COVID-19 Asmita Samadder, Sisir Nandi, Rishita Dey
13 [GO] 2022―Oct―18 Therapeutic Targets and Computational Approaches on Drug Development for COVID-19 Anusuya Shanmugam
14 [GO] 2022―Oct―18 Effective Chemicals against Novel Coronavirus (COVID-19) in China Wei Liu
15 [GO] 2022―Oct―18 Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China Zhang Qi
16 [GO] 2022―Oct―18 Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery Ariane Sternberg
17 [GO] 2022―Aug―03 Coronavirus Disease COVID-19: A New Threat to Public Health
18 [GO] 2022―Jul―27 Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview. Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Nouhaila Ait Lahcen, Didier Villemin, Rachid Daoud, et al. (+2)
19 [GO] 2022―Jul―17 The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area Meng, ZJ
20 [GO] 2022―Jul―07 Therapeutics for the management of cytokine release syndrome in COVID-19 Shampa Ghosh, Shantanu Durgvanshi, Sung Soo Han, Rakesh Bhaskar, Jitendra Kumar Sinha
21 [GO] 2022―Jul―07 Novel Therapeutic Strategies for the Management of Neuropathology and Neuroprotection in COVID-19 Cindy Bandala
22 [GO] 2022―May―17 COVID-19 in G6PD-deficient patients, oxidative stress, and neuropathology Beatriz Hernández-Ochoa, Daniel Ortega-Cuellar, Abigail González-Valdez, Noemí Cárdenas-Rodríguez, Julieta Griselda Mendoza-Torreblanca, Itzel Jatziri Contreras-García, et al. (+3)
23 [GO] 2022―May―07 Mental disorders and poor COVID-19 prognosis: reevaluating the relationship through Ca2+/cAMP signalling Leandro Bueno Bergantin
24 [GO] 2022―Apr―27 A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery of New Potential Antiviral Compounds Juan A. Castillo-Garit, Yudith Cañizares-Carmenate, Hai Pham-The, Virginia Pérez-Doñate, Francisco Torrens, Facundo Pérez-Giménez
25 [GO] 2022―Apr―06 Potential Neuroprotective Effect of Cannabinoids in Covid-19 Patients. José Luis Cortes-Altamirano, Ariadna Yáñes-Pizaña, Samuel Reyes-Long, González-Maciel Angélica, Cindy Bandala, Herlinda Bonilla-Jaime, Alfonso Alfaro-Rodríguez
26 [GO] 2022―Apr―03 Vitamin D and its possible relationship to neuroprotection in COVID-19: evidence in the literature Saray Quintero-Fabián, Cindy Bandala, Luz Adriana Pichardo-Macías, Itzel Jatziri Contreras-García, Saúl Gómez-Manzo, Beatriz Hernández-Ochoa, et al. (+3)
27 [GO] 2022―Mar―08 BIBLIOMETRIC ANALYSIS: NANOTECHNOLOGY AND COVID-19 Claure Nain Lunardi, Fernanda Lima Subrinho, Mirella Paula de Freitas Barros, Raiane Cavalcante Lima, Ana Clara Magalhaes de Queiroz Melo, Daniela de Melo Barbosa, et al. (+6)
28 [GO] 2022―Mar―04 HDAC inhibition as neuroprotection in COVID-19 infection Yudibeth Sixto-López, José Correa-Basurto
29 [GO] 2021―Jul―28 Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment Harekrishna Roy, Asha Gummadi, Bhabani Shankar Nayak, Sisir Nandi, Anil Kumar Saxena
30 [GO] 2021―Jul―19 Protease Inhibitors as Promising Weapons against COVID-19: Focus on Repurposing of Drugs Used to Treat HIV and HCV infections Luciana Jesus da Costa, Matheus Mendonça Pereira, Lívia de Souza Ramos, Thaís Pereira de Mello, Laura Nunes Silva, Marta Helena Branquinha, André Luis Souza dos Santos
31 [GO] 2021―Jun―19 Chimeric virus-like particles of universal antigen epitopes of coronavirus and phage Qβ coat protein trigger the production of neutralizing antibodies Yukun Guo, Ruizhen Guo, Yingxian Ma, Wenru Chang, Shengli Ming, Guoyu Yang, Yujie Guo
32 [GO] 2021―Jun―15 COVID-19 and diabetes mellitus: potential metabolic associations Pedro Henrique Abreu da Silva, Andressa Santos Garcia, Fábio Aguiar Alves, André Luis Souza dos Santos, Cátia Lacerda Sodré
33 [GO] 2021―May―13 The effect of recombinant human interferon alpha nasal drops to prevent COVID-19 pneumonia for medical staff in an epidemic area Zhongji Meng, Tongyu Wang, Li Chen, Xinhe Chen, Longti Li, Xueqin Qin, et al. (+2)
34 [GO] 2021―Mar―31 Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance Gabriela Seabra, Roberta Ferreira Ventura Mendes, Luiz Felipe Vieira dos Santos Amorim, Ingrid Vianez Peregrino, Marta Helena Branquinha, André Luis Souza dos Santos, Ana Paula Ferreira Nunes
35 [GO] 2021―Jan―19 An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong
36 [GO] 2020―Dec―08 An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong
37 [GO] 2020―Nov―13 Recent Advances in Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses Arti Sharma, Kajal Kaliya, Sushil K. Maurya
38 [GO] 2020―Nov―03 Most Promising Compounds for Treating COVID-19 and Recent Trends in Antimicrobial & Antifungal Agents Anuraj Nayarisseri
39 [GO] 2020―Oct―01 Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic Mohamed Abouleish, Ali El-Keblawy, Kareem A. Mosa, Sameh S.M. Soliman
40 [GO] 2020―Oct―01 Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options Laura Nunes Silva, Thaís Pereira de Mello, Lívia de Souza Ramos, Marta Helena Branquinha, Maryam Roudbary, André Luis Souza dos Santos
41 [GO] 2020―Sep―23 Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2 Satya P. Gupta
42 [GO] 2020―Jul―20 COVID-19: Small-Molecule Clinical Trials Landscape Leonardo L.G. Ferreira, Adriano D. Andricopulo
43 [GO] 2020―Jul―17 Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV) Gabriela Cristina Soares Rodrigues, Mayara dos Santos Maia, Renata Priscila Barros de Menezes, Andreza Barbosa Silva Cavalcanti, Natália Ferreira de Sousa, Érika Paiva de Moura, et al. (+3)
44 [GO] 2020―Jul―16 Therapeutic targets and computational approaches on drug development for COVID-19 Anusuya Shanmugam, Nisha Muralidharan, D. Velmurugan, M. Michael Gromiha
45 [GO] 2020―Jul―04 Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation. Ravina Khandelwal, Anuraj Nayarisseri, Maddala Madhavi, Chandrabose Selvaraj, Umesh Panwar, Khushboo Sharma, et al. (+2)
46 [GO] 2020―May―19 The Evolution of Computational Chemistry Along with Coronaviruses Weng Ieong Tou, Kuok Wa Tam, Hou Ng
47 [GO] 2020―May―17 Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery Ariane Sternberg, Dwight L. McKee, Cord Naujokat
48 [GO] 2020―May―12 COVID-19 Pandemic - Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis? Yogesh Kumar, Akanksha Jain
49 [GO] 2020―May―12 COVID-19: An Update on Clinical Trials Yogesh Kumar, Anil Kumar Singh, Shiv Kumar
50 [GO] 2020―May―12 Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China Zhang Qi, Yu Yu
51 [GO] 2020―Apr―13 Coronavirus Disease (COVID-19) Pandemic: A Race Against Time Amit Kumar Banerjee, Neelima Arora
52 [GO] 2020―Mar―05 Effective Chemicals against Novel Coronavirus (COVID-19) in China Wei Liu, Hai-liang Zhu, Yongtao Duan
53 [GO] 2020―Mar―05 Coronavirus Disease COVID-19: A New Threat to Public Health Sumit Kumar, Brijesh Rathi
54 [GO] 2020―Mar―05 China Coronavirus Outbreak: All the Latest Updates Luciana Scotti, Marcus T. Scotti
 [1] 

54 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.004 sec